Oxepanes
Medchemexpress LLC Kaempferol-7-O-β-D-glucopyranoside | 16290-07-6 | 448.38 | 5 MG
Kaempferol-7-O-β-D-glucopyranoside is a flavonoid glycoside found in the root bark of *Cudrania tricuspidata*. It has demonstrated antioxidant activity by inhibiting Cu2+-induced lipid peroxidation of low-density lipoprotein and by scavenging DPPH free radicals.
- Inhibits lipid peroxidation.
- Possesses antioxidant properties.
- Scavenges free radicals.
(CCC1CCC2OC2C1)OC | 1g | 537724838](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502142479.JPG-250.jpg)
eMolecules 97802-57-8 | 2-(4-Epoxycyclohexyl) ethylmethyl dimethoxy silane | Oakwood Chemical | MFCD05663923 | 230.379 | C11H22O3Si | 0.000 | CO[Si](C)(CCC1CCC2OC2C1)OC | 1g | 537724838
2-(4-Epoxycyclohexyl) ethylmethyl dimethoxy silane | Oakwood Chemical | 97802-57-8 | MFCD05663923 | 230.379 | C11H22O3Si | 0.000 | CO[Si](C)(CCC1CCC2OC2C1)OC | 1g | 537724838
![Medchemexpress LLC Benzoic acid, 4-[5-(4,7-dimethyl-2-benzofuranyl)-1,2,4-oxadiazol-3-yl]- | 1952276-71-9 | 98.9% | 334.33 | 50 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000439664-Logo.png-250.jpg){kind=logo}
Medchemexpress LLC Benzoic acid, 4-[5-(4,7-dimethyl-2-benzofuranyl)-1,2,4-oxadiazol-3-yl]- | 1952276-71-9 | 98.9% | 334.33 | 50 MG
KCL-286 (C286) is an orally active and brain-penetrant retinoic acid receptor (RAR) β2 agonist (EC50 = 1.9 nM). It activates RARβ2 in injured neurons, inducing axonal regeneration and modulating neuroinflammation and extracellular matrix molecules. It can also modulate the expression of chondroitin sulfate proteoglycans (CSPGs) by neuronal secretion of decorin, promoting myelination and aiding axonal growth.
- Targets RARβ2 with selectivity over RAR α and RAR γ.
- Activates RARβ2 in injured neurons.
- Induces axonal regeneration of spinal and sensory nerves.
- Modulates neuroinflammation and extracellular matrix molecules.
- Promotes myelination and aids axonal growth.
- Suitable for research in spinal cord injury and traumatic nerve injury.
Chem-Impex International, Inc. 1,6-Anhydro-b-D-glucopyranose | MFCD00063248 | 5G
1,6-Anhydro-b-D-glucopyranose, MFCD00063248, 5G
Medchemexpress LLC PAP 248-286 (acetate) | 98.9% | 4551.39 | 1 MG
PAP 248-286 (Prostatic acid phosphatase (248-286)) acetate is a biologically active peptide. It is a semen-derived enhancer of viral infection (SEVI) factor found in semen. This peptide significantly increases HIV infection by enhancing virion attachment to target cells.
- Biologically active peptide
- Semen-derived enhancer of viral infection (SEVI) factor
- Enhances virion attachment to target cells, increasing HIV infection
- Potential applications in COVID-19 anti-viral research
eMolecules 25320-79-0 | 2-Naphthyl-a-D-glucopyranoside | Chem-Impex | MFCD00703082 | 306.314 | C16H18O6 | 99.000 | OCC1OC(Oc2ccc3ccccc3c2)C(O)C(O)C1O | 1g | 112755033
2-Naphthyl-a-D-glucopyranoside | Chem-Impex | 25320-79-0 | MFCD00703082 | 306.314 | C16H18O6 | 99.000 | OCC1OC(Oc2ccc3ccccc3c2)C(O)C(O)C1O | 1g | 112755033
Selleck Chemical LLC FHD-286-E1178-25MG
FHD-286 is a BRG1/BRM ATPase inhibitor for the treatment of BAF-related disorders such as acute myeloid leukemia
Medchemexpress LLC NCT-502 10mg | 1542213-00-2 | 395.45 g·mol⁻1 | C18H20F3N5S | 10 MG
NCT-502 is a small-molecule inhibitor of human phosphoglycerate dehydrogenase (PHGDH). It reduces glucose-derived serine production and is cytotoxic to PHGDH-dependent cancer cells, making it suitable for biochemical and cellular studies of serine biosynthesis and metabolic vulnerabilities in cancer research.
- PHGDH inhibitor (IC50 3.7 μM).
- High purity (~98.59%).
- Molecular weight 395.45 g·mol⁻1; formula C18H20F3N5S.
- Soluble in DMSO (~130 mg/mL); sonication recommended for dissolution.
- Stable when stored as powder at -20°C (up to 3 years) or 4°C (up to 2 years).
- Recommended frozen storage for solutions: -80°C (up to 2 years) or -20°C (up to 1 year).
![eMolecules 10217-34-2 | (2-(7-Oxabicyclo[4.1.0]heptan-3-yl)ethyl)triethoxysilane | Oakwood Chemicals | MFCD00069159 | 288.459 | C14H28O4Si | 95.000 | CCO[Si](CCC1CCC2OC2C1)(OCC)OCC | 25g | 480164309](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502151416.JPG-250.jpg)
eMolecules 10217-34-2 | (2-(7-Oxabicyclo[4.1.0]heptan-3-yl)ethyl)triethoxysilane | Oakwood Chemicals | MFCD00069159 | 288.459 | C14H28O4Si | 95.000 | CCO[Si](CCC1CCC2OC2C1)(OCC)OCC | 25g | 480164309
(2-(7-Oxabicyclo[4.1.0]heptan-3-yl)ethyl)triethoxysilane | Oakwood Chemicals | 10217-34-2 | MFCD00069159 | 288.459 | C14H28O4Si | 95.000 | CCO[Si](CCC1CCC2OC2C1)(OCC)OCC | 25g | 480164309
Apexbio Technology LLC FHD-286-10MG
FHD-286 (CAS No 2671128-05-3) is a novel compound in the field of biomedical research primarily categorized under oncology Originally developed from a series of studies exploring targeted cancer therapies FHD-286 acts by inhibiting specific signaling pathways that are crucial for tumor cell proliferation and survival It exhibits potent activity within the nanomolar to low micromolar range making it a valuable tool for in vitro experiments Common applications include its use in various cell models such as breast and lung cancer cells as well as in vivo studies involving xenograft models in mice Additionally FHD-286 is frequently utilized in drug screening programs focused on identifying new therapeutic agents against resistant cancer types Experimental concentrations are typically dependent on the specific research design allowing for tailored applications in diverse experimental settings